Skip to main content
Erschienen in: Obesity Surgery 10/2008

01.10.2008 | Research Article

Laparoscopic Sleeve Gastrectomy without an Over-Sewing of the Staple Line

verfasst von: Mojmir Kasalicky, David Michalsky, Jitka Housova, Martin Haluzik, Daniel Housa, Denisa Haluzikova, Martin Fried

Erschienen in: Obesity Surgery | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

In the past few years, laparoscopic sleeve gastrectomy (LSG) became a widely used bariatric method. Based on results of recent LSG studies, LSG is being increasingly used even as a single bariatric method. On contrary with some other reports, we do not reinforce the LSG staple line with over-sewing. Our pilot study presents treatment outcomes and results 18 months after LSG.

Methods

Sixty-one consecutive morbidly obese (MO) patients (19 male and 42 female) who underwent LSG from January 2006 to May 2008 were included into the study. The mean age, height, and weight were 37.3 years (29–57), 168 cm (151–187), and 118 kg (97–181), respectively, while mean body mass index (BMI) was 41.8 (36.1–60.4). LSG started at 6 cm from pylorus and ended at the angle of Hiss. For gastric sleeve calibration 38F, intragastric tube was used. All 61 LSG were performed without over-sewing of the staple line. In the last 24 cases, the staple line was covered with Surgicel™ strips, which were however placed without any fixation to the underlying gastric tissue.

Results

Mean operating time was 105 min (80–170) and no conversion to open surgery. An 18-month follow-up was recorded in 39 MO patients. The mean weight loss was 31.3 (range, 21–67 kg) and mean % excess BMI loss reached 72% (range, 64–97%). Neither leak nor disruptions of the staple line and/or sleeve dilatation were recorded.

Conclusion

LSG is an effective and safe bariatric procedure with low incidence of complications and mortality in our experience.
Literatur
1.
Zurück zum Zitat Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg 2007;17:1297–305.PubMedCrossRef Weiner RA, Weiner S, Pomhoff I, et al. Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume. Obes Surg 2007;17:1297–305.PubMedCrossRef
2.
Zurück zum Zitat Chu CA, Gagner M, Quin T, et al. Two-stage laparoscopic biliopancreatic diversion with duodenal switch: an alternative approach to super-super morbid obesity. Surg Endosc 2003;16:S069. (Abstract). Chu CA, Gagner M, Quin T, et al. Two-stage laparoscopic biliopancreatic diversion with duodenal switch: an alternative approach to super-super morbid obesity. Surg Endosc 2003;16:S069. (Abstract).
3.
Zurück zum Zitat Gumbs AA, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg 2007;17:962–9.PubMedCrossRef Gumbs AA, Gagner M, Dakin G, et al. Sleeve gastrectomy for morbid obesity. Obes Surg 2007;17:962–9.PubMedCrossRef
4.
Zurück zum Zitat Selecchia G, Boru C, Pecchia A, et al. Effectivness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbities in super-obese high-risk patients. Obes Surg 2006;16:1138–44.CrossRef Selecchia G, Boru C, Pecchia A, et al. Effectivness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbities in super-obese high-risk patients. Obes Surg 2006;16:1138–44.CrossRef
5.
Zurück zum Zitat Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: multi-purpose bariatric operation. Obes Surg 2005;15:1124–8.PubMedCrossRef Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: multi-purpose bariatric operation. Obes Surg 2005;15:1124–8.PubMedCrossRef
6.
Zurück zum Zitat Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric for hi-risk patients: initial result in 10 patients. Obes Surg 2005;15:1030–3.PubMedCrossRef Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric for hi-risk patients: initial result in 10 patients. Obes Surg 2005;15:1030–3.PubMedCrossRef
7.
Zurück zum Zitat Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024–9.PubMedCrossRef Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005;15:1024–9.PubMedCrossRef
8.
Zurück zum Zitat Moon Han S, Kim WW, Oh JH. Result of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly Korean patients. Obes Surg 2005;15:1469–75.PubMedCrossRef Moon Han S, Kim WW, Oh JH. Result of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly Korean patients. Obes Surg 2005;15:1469–75.PubMedCrossRef
9.
Zurück zum Zitat Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg 2007;17:1069–74.PubMedCrossRef Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg 2007;17:1069–74.PubMedCrossRef
10.
Zurück zum Zitat Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: result after 1 and 3 years. Obes Surg 2006;16:1450–6.PubMedCrossRef Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: result after 1 and 3 years. Obes Surg 2006;16:1450–6.PubMedCrossRef
11.
Zurück zum Zitat Kasalicky M, Michalsky D, Housova J, et al. Laparoscopic gastric tubulisation - sleeve gastrectomy—another option for bariatric food intake restriction in morbidly obese subjects. Rozhl Chir 2007;86:601–6.PubMed Kasalicky M, Michalsky D, Housova J, et al. Laparoscopic gastric tubulisation - sleeve gastrectomy—another option for bariatric food intake restriction in morbidly obese subjects. Rozhl Chir 2007;86:601–6.PubMed
12.
Zurück zum Zitat Fried M, Hainer V, Basdevand A, et al. Interdisciplinary European guidelines for surgery of severe (morbid) obesity. Obes Surg 2007;17:260–70.PubMedCrossRef Fried M, Hainer V, Basdevand A, et al. Interdisciplinary European guidelines for surgery of severe (morbid) obesity. Obes Surg 2007;17:260–70.PubMedCrossRef
13.
Zurück zum Zitat Bernante P, Foletto M, Busetto L, et al. Feasibility of laparoscopic sleeve gastrectomy as a revisional procedure for prior laparoscopic gastric banding. Obes Surg 2006;16:1327–30.PubMedCrossRef Bernante P, Foletto M, Busetto L, et al. Feasibility of laparoscopic sleeve gastrectomy as a revisional procedure for prior laparoscopic gastric banding. Obes Surg 2006;16:1327–30.PubMedCrossRef
14.
Zurück zum Zitat Gagner M, Inabnet WB, Pomp A. Laparoscopic sleeve gastrectomy with second stage biliopancreatic diversion and duodenal switch in the superobese. In: Inabnet WB, DeMaria EJ, Ikramuddin S, editors. Laparoscopic bariatric surgery. Philadelphia: Lippincott William & Wilkins; 2005. pp. 143–50. Gagner M, Inabnet WB, Pomp A. Laparoscopic sleeve gastrectomy with second stage biliopancreatic diversion and duodenal switch in the superobese. In: Inabnet WB, DeMaria EJ, Ikramuddin S, editors. Laparoscopic bariatric surgery. Philadelphia: Lippincott William & Wilkins; 2005. pp. 143–50.
15.
Zurück zum Zitat Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16:1323–6.PubMedCrossRef Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16:1323–6.PubMedCrossRef
16.
Zurück zum Zitat Pereferrer FS, González MH, Rovira FA, et al. Influence of sleeve gastrectomy on several experimental models of obesity: Metabolic and hormonal implications. Obes Surg 2008;18:97–108.PubMedCrossRef Pereferrer FS, González MH, Rovira FA, et al. Influence of sleeve gastrectomy on several experimental models of obesity: Metabolic and hormonal implications. Obes Surg 2008;18:97–108.PubMedCrossRef
17.
Zurück zum Zitat Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg 2006;16:554–9.PubMedCrossRef Kotidis EV, Koliakos G, Papavramidis TS, et al. The effect of biliopancreatic diversion with pylorus-preserving sleeve gastrectomy and duodenal switch on fasting serum ghrelin, leptin and adiponectin levels: is there a hormonal contribution to the weight-reducing effect of this procedure? Obes Surg 2006;16:554–9.PubMedCrossRef
18.
Zurück zum Zitat Braghetto I, Korn O, Valladares H, et al. Laparoscopic sleeve gastrectomy: Surgical technique, indications and clinical results. Obes Surg 2007;17:1442–50.PubMedCrossRef Braghetto I, Korn O, Valladares H, et al. Laparoscopic sleeve gastrectomy: Surgical technique, indications and clinical results. Obes Surg 2007;17:1442–50.PubMedCrossRef
19.
Zurück zum Zitat Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy—a restrictive procedure? Obes Surg 2007;17:57–62.PubMedCrossRef Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy—a restrictive procedure? Obes Surg 2007;17:57–62.PubMedCrossRef
20.
Zurück zum Zitat Cottam D, Qureshi FG, Mattar DG, et al. Laparoscopic sleeve gastretomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006;20:859–63.PubMedCrossRef Cottam D, Qureshi FG, Mattar DG, et al. Laparoscopic sleeve gastretomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006;20:859–63.PubMedCrossRef
Metadaten
Titel
Laparoscopic Sleeve Gastrectomy without an Over-Sewing of the Staple Line
verfasst von
Mojmir Kasalicky
David Michalsky
Jitka Housova
Martin Haluzik
Daniel Housa
Denisa Haluzikova
Martin Fried
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Obesity Surgery / Ausgabe 10/2008
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9635-3

Weitere Artikel der Ausgabe 10/2008

Obesity Surgery 10/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.